Management of mitral regurgitation in patients undergoing transcatheter aortic valve replacement

Mitral regurgitation (MR) is common among patients with severe aortic stenosis (AS), but its management remains largely empirical. Conflicting results have been reported on how MR impacts on outcomes after surgical or transcatheter aortic valve replacement (TAVR), and the effects of aortic valve replacement on the evolution of MR are largely unpredictable [1]. The optimal management strategy therefore remains controversial, particularly when MR is less than severe. In the study by Abdelghani et al.
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research